MINNEAPOLIS, Nov. 14, 2019 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq: GWGH), a financial services holding company committed to transforming the alternative asset industry through innovative liquidity products and related services for the owners of illiquid alternative investments, today announced its financial and operating results for the third quarter ended September 30, 2019.

Third Quarter 2019 Financial and Operating Highlights

  • Reported continued record realizations from our portfolio of life insurance:
    • Realized $27.5 million of face amount of policy benefits from 22 life insurance policies during the quarter.
    • Reported additional policy realizations of $14.5 million from twelve policies through November 14, 2019.
    • Total 2019 year-to-date realizations of $95.5 million from 73 policies – compared to $71.1 million from 62 policies for the entire year of 2018.
    • Ended the quarter with a life insurance portfolio of $2.06 billion in face amount of policy benefits consisting of 1,174 policies.
  • Reported continued success raising capital to fund our business through the L Bond investment product:
    • Restarted sales of L Bonds in early August.
    • Experienced consistent near record levels of demand since the restart with combined L Bond sales for August and September of $107 million.
    • Hired five new sales executives with strong experience in the sales and marketing of alternative investments.
  • Began the process of separating the Company’s insurance technology subsidiaries, Life Epigenetics Inc. and YouSurance General Agency, LLC by contributing these subsidiaries to a newly formed limited liability company InsurTech Holdings, LLC, which is a subsidiary of GWGH and managed by InsurTech Management, LLC, a company controlled by Jon Sabes, former President and Chief Executive Officer of GWGH.
  • Reported the inclusion of GWGH in the Russell 2000 Index, the well-known index of small-cap stocks.
  • Reported total liquidity (cash, restricted cash and policy benefits receivable) of $144.7 million at November 12, 2019.

“We believe we have put in place many of the key elements we need to successfully execute our strategy of providing products and services to the vast market of owners who hold illiquid alternative investments,” said Murray Holland, GWGH’s Chief Executive Officer. “We look forward to leveraging the best of GWGH and The Beneficient Company Group, L.P. to create a successful model that serves the growing market of investors who need liquidity.”

1.     Financial & Operating Highlights

($ Thousands except per share information) Q3 2019 Q3 2018 YTD Q3 2019 YTD Q3 2018
Revenue $22,211  $20,937  $71,438  $59,794 
Expenses  43,570   31,459   127,415   79,551 
Per Share Data1:               
Net Income (Loss)2  (0.75)  (2.52)  (2.09)  (5.50)
Capital Raised (L Bonds)  107,012   68,884   278,239   166,082 
Liquidity3,  91,254   131,416   91,254   131,416 
Life Insurance Portfolio4  2,064,156   1,961,598   2,064,156   1,961,598 
Life Insurance Acquired4  3,155   120,430   96,321   333,078 
Face Value of Matured Policies  27,470   7,973   80,927   50,100 
TTM Benefits / Premiums5  164.9%  135.8%  164.9%  135.8%

  (1)       Attributable to common shareholders
  (2)       Per basic and fully diluted share outstanding
  (3)       Includes cash, restricted cash and policy benefits receivable
  (4)       Face amount of policy benefits
  (5)       The ratio of policy benefits realized to premiums paid on a trailing twelve month (TTM) basis
             
2.     Revenue and Expense Discussion

Third Quarter 2019 vs. Third Quarter 2018:

  • Total revenue was $22.2 million in the current period, compared to $20.9 million in the year ago period primarily due to:
    • Net revenue recognized at matured policy event was $14.3 million higher, unrealized gain on acquisition was $8.5 million lower (as a result of lower life insurance purchases) and change in estimated probabilistic cash flows net of premium and fees was $3.6 million lower.
    • Net interest income on our commercial loan, exchange note, and Liquid Trust note was $0.6 million lower.
    • Other interest income decreased $0.2 million.
  • Total expenses were $43.6 million in the current period, compared to $31.5 million in the year ago period primarily due to:
    • Interest and fees increased by $6.5 million. This change was driven by increased interest on L Bonds of $5.2 million as a result of additional amounts outstanding, increased interest on Seller Trust L Bonds of $2.6 million which were outstanding the entire third quarter of 2019 versus a partial quarter in the year ago period, and partially offset by a decrease in interest on our senior credit facility of $1.3 million.
    • Operating expenses increased by $5.6 million. Compensation and professional expenses increased by $3.6 million and $1.2 million, respectively, primarily resulting from performance share unit expense and retention incentives associated with the Purchase and Contribution transaction (the strategic transaction with The Beneficient Company Group, L.P. (Beneficient) which occurred in April 2019), as well as increases in legal, audit and other professional fees. Other expenses also increased by $0.8 million due to increases in contract labor, IT expense, travel, and business insurance (also largely driven by the Purchase and Contribution transaction with Beneficient).

Third Quarter Year to Date 2019 vs. Third Quarter Year to Date 2018:

  • Total revenue was $71.4 million in the current period, compared to $59.8 million in the year ago period primarily due to:
    • Net revenue recognized at matured policy event was $29.1 million higher, charges on life expectancy updates were $4.9 million lower, unrealized gain on acquisition was $15.0 million lower (as a result of lower life insurance purchases), and a change in estimated probabilistic cash flows net of premiums and fees and change in life expectancy was $12.7 million lower as compared to the year ago period.
    • Interest income from the commercial loan, exchangeable note, and Liquid Trust promissory note increased $5.4 million and other income decreased $0.1 million.
  • Total expenses were $127.4 million in the current period, compared to $79.6 million in the year ago period primarily due to:
    • Interest and fees increased by $28.7 million year over year. Outstanding L Bonds increased over this time period resulting in $16.6 million of additional interest expense, Seller Trust L Bonds, which were issued in August 2018, increased interest expense by $16.4 million and senior credit facility interest decreased by $4.3 million.
    • Operating expenses increased by $19.1 million. Compensation and professional expenses increased by $8.6 million and $6.5 million, respectively, primarily resulting from performance share unit expense and retention incentives associated with the Purchase and Contribution transaction, as well as increases in legal and professional fees. Other expenses also increased by $4.0 million primarily driven by an increase in business insurance purchased in connection with the Purchase and Contribution transaction with Beneficient.
       

3.     Life Insurance Portfolio Statistics

Portfolio Summary:

Total life insurance portfolio face value of policy benefits $2,064,156,000 
Average face value per policy $1,758,000 
Average face value per insured life $1,887,000 
Average age of insured (years)*  82.3 
Average life expectancy estimate (years)*  7.3 
Total number of policies  1,174 
Number of unique lives  1,094 
Demographics  74% Male; 26% Female 
Number of smokers  45 
Largest policy as % of total portfolio face value  0.64%
Average policy as % of total portfolio face value  0.09%
Average annual premium as % of face value  3.2%

*    Averages presented in the table are weighted averages.

 

Distribution of Policies and Benefits by Current Age of Insured:

          Percentage of Total    
Min Age Max Age Number
of
Policies
  Policy
Benefits
  Number
of
Policies
  Policy
Benefits
  Wtd. Avg.
LE (Years)
 
95 101  18  $36,052,000   1.5%  1.8%  2.2 
90 94  145   284,908,000   12.4%  13.8%  3.3 
85 89  249   587,733,000   21.2%  28.5%  5.1 
80 84  251   456,526,000   21.4%  22.1%  7.9 
75 79  223   341,449,000   19.0%  16.5%  9.8 
70 74  214   284,739,000   18.2%  13.8%  11.1 
60 69  74   72,749,000   6.3%  3.5%  11.6 
Total    1,174  $2,064,156,000   100.0%  100.0%  7.3 


4.      Life Insurance Policy Originations

Life Insurance Portfolio Activity:

   Three Months Ended
September 30
  Nine Months Ended
September 30
 
   2019  2018  2019  2018 
              
Total policy benefits purchased $3,155,000 $120,430,000 $96,321,000 $333,078,000 
Life insurance policies purchased  6  89  81  233 
Average policy benefit purchased $526,000 $1,353,000 $1,189,000 $1,430,000 
Direct policy benefits purchased $1,305,000 $16,524,000 $19,397,000 $29,561,000 
Direct insurance policies purchased  3  17  27  39 


5.      Additional Information
       
Gain (Loss) on Life Insurance Policies:

  Three Months Ended
September 30,
  Nine Months Ended
September 30,
 
  2019  2018  2019  2018 
Change in estimated probabilistic cash flows(1) $17,908,000  $19,069,000  $52,161,000  $55,483,000 
Unrealized gain on acquisitions(2)  472,000   9,021,000   6,775,000   21,790,000 
Premiums and other annual fees  (17,219,000)  (14,765,000)  (49,000,000)  (39,670,000)
Change in discount rates(3),(4)            
Change in life expectancy evaluation(5)     73,000      (4,890,000)
Face value of matured policies  27,470,000   7,973,000   80,927,000   50,100,000 
Fair value of matured policies  (10,839,000)  (5,650,000)  (31,590,000)  (29,883,000)
Gain (loss) on life insurance policies, net $17,792,000  $15,721,000  $59,273,000  $52,930,000 


(1)Change in fair value of expected future cash flows relating to our investment in life insurance policies that are not specifically attributable to changes in life expectancy, discount rate changes or policy maturity events.
(2)Gain resulting from fair value in excess of the purchase price for life insurance policies acquired during the reporting period.
(3)The discount rate applied to estimate the fair value of the portfolio of life insurance policies we own was 8.25% at each quarter end in 2019 and at December 31, 2018. This discount rate was 10.45% at September 30, 2018 and December 31, 2017.
(4)The discount rate of 8.25% is based on our “longest life expectancy” methodology (among other factors) which was adopted at December 31, 2018, whereas the discount rate of 10.45% is based on our historical “average life expectancy methodology” (among other factors). See our 2018 Form 10-K filed on July 9, 2019 with Securities and Exchange Commission for additional information.
(5)The change in fair value due to updating life expectancy estimates on certain life insurance policies in our portfolio.


Policy Benefits Realized and Premiums Paid (TTM):  

Quarter End Date Portfolio
Face Amount ($)
  12-Month
Trailing
Benefits Realized ($)
  12-Month
Trailing Premiums Paid ($)
  12-Month
Trailing
Benefits/Premium
Coverage
Ratio 
September 30, 2015  878,882,000   44,482,000   25,313,000   175.7%
December 31, 2015  944,844,000   31,232,000   26,650,000   117.2%
March 31, 2016  1,027,821,000   21,845,000   28,771,000   75.9%
June 30, 2016  1,154,798,000   30,924,000   31,891,000   97.0%
September 30, 2016  1,272,078,000   35,867,000   37,055,000   96.8%
December 31, 2016  1,361,675,000   48,452,000   40,239,000   120.4%
March 31, 2017  1,447,558,000   48,189,000   42,753,000   112.7%
June 30, 2017  1,525,363,000   49,295,000   45,414,000   108.5%
September 30, 2017  1,622,627,000   53,742,000   46,559,000   115.4%
December 31, 2017  1,676,148,000   64,719,000   52,263,000   123.8%
March 31, 2018  1,758,066,000   60,248,000   53,169,000   113.3%
June 30, 2018  1,849,079,000   76,936,000   53,886,000   142.8%
September 30, 2018  1,961,598,000   75,161,000   55,365,000   135.8%
December 31, 2018  2,047,992,000   71,090,000   52,675,000   135.0%
March 31, 2019  2,098,428,000   87,045,000   56,227,000   154.8%
June 30, 2019  2,088,445,000   82,421,000   59,454,000   138.6%
September 30, 2019  2,064,156,000   101,918,000   61,805,000   164.9%

Webcast/Conference Call Details

Management will host a webcast/conference call Thursday, November 21 at 4:30 p.m. EST to discuss our financial and operating results. The webcast will give viewers audio and access to PowerPoint slides that illustrate points made during the call. To register for the call and webcast, go to http://get.gwgh.com/q32019webcastinvite.

After the webcast is completed, a replay of it can be accessed at http://get.gwgh.com/q32019webcast.

About GWG Holdings, Inc. 

GWG Holdings, Inc. (Nasdaq: GWGH), a financial services holding company committed to transforming the alternative asset industry through innovative liquidity products and related services for the owners of illiquid alternative investments, is the parent company of GWG Life which owns a portfolio of $2.06 billion in face value of life insurance policy benefits as of September 30, 2019. GWGH has executed a series of strategic transactions with The Beneficient Company Group, L.P., a financial services company providing proprietary liquidity solutions to owners of alternative assets, resulting in the closer alignment of the two companies. This alignment includes changing a number of GWGH management and the board of directors with Beneficient management, directors and affiliated parties. GWGH has also created an independent, special committee of the GWGH board of directors. GWGH’s subsidiary InsurTech Holdings, LLC, owns two companies exploring business applications for the emerging science of epigenetics: Life Epigenetics which is working to commercialize epigenetic technology for the life insurance and related industries; and YouSurance, a digital life insurance agency whose goal is to use epigenetic testing to support health and wellness while reducing the cost of insurance.

For more information about GWG Holdings, email info@gwgh.com or visit www.gwgh.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and objectives of management are forward-looking statements. The words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "would," "target" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among other things, statements about our estimates regarding future revenue and financial performance. We may not actually achieve the expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the expectations disclosed in the forward-looking statements that we make. More information about potential factors that could affect our business and financial results is contained in our filings with the Securities and Exchange Commission. Additional information will also be set forth in our future quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings that we make with the Securities and Exchange Commission. We do not intend, and undertake no duty, to release publicly any updates or revisions to any forward-looking statements contained herein.

Media Contact:
Dan Callahan
Director of Communication
GWG Holdings, Inc.
(612) 746-1935
dcallahan@gwgh.com

GWG HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

  September 30,
2019
(unaudited)
  December 31,
2018
 
ASSETS      
Cash and cash equivalents $65,680,464  $114,587,084 
Restricted cash  8,204,705   10,849,126 
Investment in life insurance policies, at fair value  807,518,088   747,922,465 
Life insurance policy benefits receivable, net  17,369,176   16,460,687 
Financing receivables from affiliates  241,185,081   184,768,874 
Equity method investment  370,652,128   360,841,651 
Other assets  50,391,311   45,437,164 
TOTAL ASSETS $1,561,000,953  $1,480,867,051 
         
LIABILITIES & STOCKHOLDERS’ EQUITY        
LIABILITIES        
Senior credit facility with LNV Corporation $131,717,520  $148,977,596 
L Bonds  830,341,949   651,402,663 
Seller Trust L Bonds  366,891,940   366,891,940 
Accounts payable  2,570,842   9,276,507 
Interest and dividends payable  16,726,344   18,555,293 
Other accrued expenses  6,700,336   4,705,170 
TOTAL LIABILITIES  1,354,948,931   1,199,809,169 
         
STOCKHOLDERS’ EQUITY        
         
REDEEMABLE PREFERRED STOCK        
(par value $0.001; shares authorized 100,000; shares outstanding 92,124 and 97,524; liquidation preference of $92,661,000 and $98,093,000 as of September 30, 2019 and December 31, 2018, respectively)  81,509,765   86,910,335 
SERIES 2 REDEEMABLE PREFERRED STOCK        
(par value $0.001; shares authorized 150,000; shares outstanding 147,604 and 148,359; liquidation preference of $148,465,000 and $149,225,000 as of September 30, 2019 and December 31, 2018, respectively)  128,307,735   129,062,704 
COMMON STOCK        
(par value $0.001; shares authorized 210,000,000; shares issued and outstanding 33,033,420 as of September 30, 2019 and 33,018,161 as of December 31, 2018)  33,033   33,018 
Additional paid-in capital  237,159,909   249,662,168 
Accumulated deficit  (240,958,420)  (184,610,343)
TOTAL STOCKHOLDERS’ EQUITY  206,052,022   281,057,882 
         
TOTAL LIABILITIES & EQUITY $1,561,000,953  $1,480,867,051 


GWG HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

  Three Months Ended  Nine Months Ended 
  September 30,
2019
  September 30,
2018
  September 30,
2019
  September 30,
2018
 
REVENUE            
Gain (loss) on life insurance policies, net $17,792,324  $15,721,513  $59,218,532  $52,930,008 
Interest and other income  4,418,655   5,215,515   12,219,762   6,863,640 
TOTAL REVENUE  22,210,979   20,937,028   71,438,294   59,793,648 
                 
EXPENSES                
Interest expense  28,289,670   21,799,332   83,751,611   55,010,519 
Employee compensation and benefits  9,136,824   5,548,771   21,084,815   12,527,139 
Legal and professional fees  2,594,467   1,421,964   10,263,230   3,751,321 
Other expenses  3,549,265   2,688,970   12,315,434   8,262,324 
TOTAL EXPENSES  43,570,226   31,459,037   127,415,090   79,551,303 
                 
INCOME (LOSS) BEFORE INCOME TAXES  (21,359,247)  (10,522,009)  (55,976,796)  (19,757,655)
INCOME TAX EXPENSE (BENEFIT)            
                 
NET INCOME (LOSS) BEFORE EARNINGS (LOSS) FROM EQUITY METHOD INVESTMENT  (21,359,247)  (10,522,009)  (55,976,796)  (19,757,655)
                 
Earnings (loss) from equity method investment  955,751      (371,281)    
                 
NET INCOME (LOSS)  (20,403,496)  (10,522,009)  (56,348,077)  (19,757,655)
                 
Preferred stock dividends  4,231,641   4,313,542   12,806,173   12,356,513 
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS $(24,635,137) $(14,835,551) $(69,154,250) $(32,114,168)
NET INCOME (LOSS) PER COMMON SHARE                
Basic $(0.75) $(2.52) $(2.09) $(5.50)
Diluted $(0.75) $(2.52) $(2.09) $(5.50)
                 
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING                
Basic  33,033,420   5,894,639   33,010,100   5,840,880 
Diluted  33,033,420   5,894,639   33,010,100   5,840,880